glp-1 drugs for type 1 diabetes More people with are using drugs, study finds, despite limited evidence on safety or effectiveness New GLP-1 Guidelines for Type
Description
Delivery technologies have advanced to include user-friendly devices like the Bydureon BCise autoinjector and other prefilled pen designs for dulaglutide and semaglutide injectable formulations (BYDUREON BCISETM 2017)
* Pancreatic lipase activity was based on the amount of free fatty acids liberated from emulsified olive oil (using human and porcine lipases that were commercially available)
doi:10.1136/bmj-2023-076410 Almandoz JP, Wadden TA, Tewksbury C, et al
Receptor agonists are widely used in treating chronic diseases such as diabetes, asthma, neurological disorders, hormonal deficiencies, and cardiovascular conditions
In the Phase 2 T2D trial, exploratory analyses showed significant reductions in liver fat content with retatrutide
